COVID-19 in patients with paracoccidioidomycosis

Macedo, Priscila Marques de; Benko, Lorena Macedo Pestana; Falcão, Eduardo Mastrangelo Marinho; Nosanchuk, Joshua D.; Almeida-Paes, Rodrigo; Valle, Antonio Carlos Francesconi do.
Artículo en Inglés | ARCA | ID: arc-60218

Documentos relacionados

  1. Screening paracoccidioidomycosis by double immunodiffusion test in a referred diagnostic center in Brazilian southeastern: an accessible tool.
  2. Oral paracoccidioidomycosis: a retrospective study of 95 cases from a single center and literature review.
  3. Compulsory notification of paracoccidioidomycosis: A 14-year retrospective study of the disease in the state of Paraná, Brazil.
  4. Distinct Pattern of Paracoccidioides lutzii, P. restrepiensis and P. americana Antigens Recognized by IgE in Human Paracoccidioidomycosis.
  5. Paracoccidioidesbrasiliensis induces IL-32 and is controlled by IL-15/IL-32/vitamin D pathway in vitro.
  6. [Paracoccidioidomycosis: chronicle of a neglected disease].
  7. COVID-19 in patients with paracoccidioidomycosis.
  8. Neuroparacoccidioidomycosis.
  9. Oral Paracoccidioidomycosis affecting women: A systematic review.
  10. Impact of COVID-19 on paracoccidioidomycosis. Which was the most influential: The pandemic or the virus?